Nuvectis Pharma, Inc.

NasdaqCM NVCT

Nuvectis Pharma, Inc. Dividend Yield on January 14, 2025: 0.00%

Nuvectis Pharma, Inc. Dividend Yield is 0.00% on January 14, 2025, a NA change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Nuvectis Pharma, Inc. 52-week high Dividend Yield is 0.00% on January 14, 2025, which is 0.00% below the current Dividend Yield.
Nuvectis Pharma, Inc. 52-week low Dividend Yield is 0.00% on January 14, 2025, which is 0.00% below the current Dividend Yield.
Nuvectis Pharma, Inc. average Dividend Yield for the last 52 weeks is 0.00%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

NasdaqCM: NVCT

Nuvectis Pharma, Inc.

CEO	Mr. Ron Bentsur M.B.A.
IPO Date	Feb. 4, 2022
Location	United States
Headquarters	1 Bridge Plaza
Employees	13
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.

Key trends

Past 5 years